EUVIMEDEUVIMED entdecken
Crossref

Endocan (ESM-1): a new marker of endothelial dysfunction. Biology, pathophysiology, and clinical applications

Bernard I. Lévy

Sang Thrombose Vaisseaux · 2026-10 · 38 (5) · 189-198

DOI: 10.1684/stv.2026.1365 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sang Thrombose Vaisseaux, 2026-10. Verfasst von Bernard I. Lévy.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Lévy, B. I. (2026). Endocan (ESM-1): a new marker of endothelial dysfunction. Biology, pathophysiology, and clinical applications. Sang Thrombose Vaisseaux, 38(5), 189-198. https://doi.org/10.1684/stv.2026.1365

Vancouver

Lévy BI. Endocan (ESM-1): a new marker of endothelial dysfunction. Biology, pathophysiology, and clinical applications. Sang Thrombose Vaisseaux. 2026;38(5):189-198. doi:10.1684/stv.2026.1365

BibTeX
@article{Lvy2026,
  author = {Lévy, Bernard I.},
  title = {Endocan (ESM-1): a new marker of endothelial dysfunction. Biology, pathophysiology, and clinical applications},
  journal = {Sang Thrombose Vaisseaux},
  year = {2026},
  volume = {38},
  number = {5},
  pages = {189--198},
  doi = {10.1684/stv.2026.1365}
}
Kostenlos starten →